EGFR Mutation Testing Practice in Advanced Non-Small Cell Lung Cancer
Jair Bar, Arnold Cyjon, Dov Flex et al. · Lung · 2014
Cited by 5 works. doi:10.1007/s00408-014-9604-7
Authors
- Jair Bar
- Arnold Cyjon
- Dov Flex
- Hadas Gantz Sorotsky
- Haim Biran
- Julia Dudnik
- Nili Peylan‐Ramu
- Nir Peled
- Hovav Nechushtan
- Maya Gips
- Rivka Katsnelson
- Shoshana Keren Rosenberg
- Ofer Merimsky
- Amir Onn
- Maya Gottfried
References
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- Cancer Statistics, 2007
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- Web-based Questionnaires: The Future in Epidemiology?